HKUMed Unveils Broader Potential of Fatty Liver Medication in Liver Cancer Prevention and Treatment
A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...
Tag: immune checkpoint inhibitors in liver cancer
Adverse Reactions to Tremelimumab, Durvalumab in Liver Cancer
In recent years, the advent of immune checkpoint inhibitors has revolutionized the therapeutic landscape of hepatocellular carcinoma (HCC), a primary ...
Predicting Liver Injury from Immunotherapy in Liver Cancer
In a groundbreaking study published in BMC Cancer, researchers have made strides in understanding and predicting liver injury induced by ...
Study Explores Immune-Related Side Effects of Liver Cancer Treatment in Latin American Patients
A groundbreaking multinational study has shed new light on immune-mediated adverse events (irAEs) associated with the combination therapy of atezolizumab ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!